Efficacy: response (continuous) YMRS/BPRS change from baseline to end of study · acute mania
1 finding from 1 review
Efficacy: response (continuous) CGI change from baseline to end of study · acute mania
1 finding from 1 review
Efficacy: response (continuous) Change in YMRS (ITT‐LOCF) from baseline to end of study · acute mania
1 finding from 1 review
Efficacy: response (continuous) CGI severity score at end of study · acute mania
1 finding from 1 review
Efficacy: response (continuous) change in BPRS (total) from baseline to end of study ‐all data · acute mania
1 finding from 1 review
Efficacy: response (continuous) change in BPRS (total) from baseline to end of study ‐all data · acute mania
1 finding from 1 review
Efficacy: response (continuous) change in BPRS (total) from baseline to end of study ‐all data · acute mania
The review found no eligible studies for this question.
1 finding from 1 review
Lithium for acute mania 2019 · Cochrane Headline outcomes only no estimate extracted
Studies not reported
No studies found
Efficacy: response (continuous) YMRS/MRS change at the end of the study · acute mania
1 finding from 1 review
Efficacy: response (continuous) YMRS change by ≥ 50% at end of study · acute mania
Lithium showed no clear difference in efficacy: response (continuous) YMRS change by ≥ 50% at end of study compared with aripiprazole (moderate certainty).
1 finding from 1 review
Efficacy: response (continuous) YMRS change by ≥ 50% at end of study · acute mania
The review found no eligible studies for this question.
1 finding from 1 review
Lithium for acute mania 2019 · Cochrane Headline outcomes only no estimate extracted
Studies not reported
No studies found
Efficacy: response (continuous) CGI change from baseline to end of study · acute mania
1 finding from 1 review
Efficacy: response (continuous) MRS mean change from baseline to end of study · acute mania
1 finding from 1 review
Efficacy: response (continuous) YMRS/BPRS change from baseline to end of study · acute mania
1 finding from 1 review
Efficacy: response (continuous) Change in YMRS (ITT‐LOCF) from baseline to end of study · acute mania
1 finding from 1 review
Functional ability · people with stroke and urinary incontinence
Physical therapy interventions probably leads to higher functional ability: mean Barthel score (continuous variables) compared with usual care or no treatment (moderate certainty).
1 finding from 1 review
MD 8.97 [1.27, 16.68]
81 participants
Moderate
Change in quality of life (continuous measure) · patients with restless legs syndrome
1 finding from 1 review
Drug abuse Self reported use of marijuana · drug‐using offenders with co‐occurring mental health problems
1 finding from 1 review
Nausea · participants aged 6 months or older undergoing surgical procedures under general anaesthesia
Supplemental IV crystalloid probably leads to lower risk of PON, defined as the presence of subjective nausea, reported… compared with control IV crystalloid volume (moderate certainty).
1 finding from 1 review
Self‐reported pain (dysmenorrhoea) at the end of treatment (continuous data): dysmenorrhoea at 6 months' · women with endometriosis
2 findings from 1 review
Observer‐based SDM measures · patients, including healthcare consumers and simulated patients
1 finding from 1 review
no estimate extracted
424 participants
Very low